Maryland 2025 Regular Session

Maryland Senate Bill SB965 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3	EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4	4	[Brackets] indicate matter deleted from existing law.
5	5	sb0965
6	6
7	7	SENATE BILL 965
8	8	J1 5lr2873
9	9	CF 5lr2968
10	10	By: Senators Carozza, Ready, and West
11	11	Introduced and read first time: January 28, 2025
12	12	Assigned to: Finance
13	13
14	14	A BILL ENTITLED
15	15
16	16	AN ACT concerning 1
17	17
18	18	Public Health – Women’s Health Care Data – Report 2
19	19
20	20	FOR the purpose of requiring the Maryland Department of Health to collect and compile 3
21	21	annual data on the costs of birth, postpartum care, pregnancy care, and abortion in 4
22	22	the State; and generally relating to reproductive health care data. 5
23	23
24	24	BY adding to 6
25	25	Article – Health – General 7
26	26	Section 20–217 through 20–220 to be under the new part “Part V. Women’s Health 8
27	27	Data Collection and Reporting” 9
28	28	Annotated Code of Maryland 10
29	29	(2023 Replacement Volume and 2024 Supplement) 11
30	30
31	31	SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 12
32	32	That the Laws of Maryland read as follows: 13
33	33
34	34	Article – Health – General 14
35	35
36	36	20–215. RESERVED. 15
37	37
38	38	20–216. RESERVED. 16
39	39
40	40	PART V. WOMEN’S HEALTH DATA COLLECTION AND REPORTING. 17
41	41
42	42	20–217. 18
43	43
44	44	THE PURPOSE OF THIS P ART IS TO COLLECT AN D REPORT DATA REGARD ING 19
45	45	THE COST OF BIRTH , POSTPARTUM CARE , PREGNANCY CARE , AND ABORTION TO : 20
46	46	2 SENATE BILL 965
47	47
48	48
49	49	(1) BETTER UNDERSTAND THE FINANCIAL IMPACT OF THESE 1
50	50	SERVICES ON INDIVIDU ALS, PROVIDERS, AND THE STATE; 2
51	51
52	52	(2) INFORM PUBLIC POLICY DECISIONS RELATED TO MATERNAL AND 3
53	53	REPRODUCTIVE HEALTH CARE; AND 4
54	54
55	55	(3) PROMOTE TRANSPARENCY AND ACCOUNTABILITY I N HEALTH 5
56	56	CARE SPENDING WHILE SAFEGUARDING THE PRI VACY AND DIGNITY OF ALL 6
57	57	INDIVIDUALS. 7
58	58
59	59	20–218. 8
60	60
61	61	(A) THE DEPARTMENT SHALL COLL ECT AND COMPILE DATA ANNUALLY 9
62	62	REGARDING THE COST O F: 10
63	63
64	64	(1) DELIVERY, INCLUDING: 11
65	65
66	66	(I) STANDARD DELIVERY COS TS; 12
67	67
68	68	(II) COSTS OF COMPLICATIONS , INCLUDING EMERGENCY 13
69	69	INTERVENTIONS AND EX TENDED HOSPITAL STAY S; AND 14
70	70
71	71	(III) NEONATAL CARE , IF APPLICABLE; 15
72	72
73	73	(2) POSTPARTUM CARE , INCLUDING: 16
74	74
75	75	(I) FOLLOW–UP MEDICAL VISITS ; AND 17
76	76
77	77	(II) COSTS ASSOCIATED WITH ADDRESSING POSTPARTU M 18
78	78	MENTAL HEALTH CONDIT IONS, INCLUDING POSTPARTUM DEPRESSION; 19
79	79
80	80	(3) PREGNANCY CARE , INCLUDING: 20
81	81
82	82	(I) ROUTINE OBSTETRIC AND GYNECOLOGICAL VI SITS; 21
83	83
84	84	(II) PRENATAL VITAMINS AND SUPPLEMENTS ; AND 22
85	85
86	86	(III) DIAGNOSTIC AND MONITO RING SERVICES , INCLUDING 23
87	87	ULTRASOUNDS AND GENE TIC TESTING; AND 24
88	88
89	89	(4) ABORTION, INCLUDING: 25
90	90
91	91	(I) PROCEDURAL COSTS ; 26 SENATE BILL 965 3
92	92
93	93
94	94
95	95	(II) COSTS ASSOCIATED WITH COMPLICATIONS OR FOL LOW–UP 1
96	96	CARE; 2
97	97
98	98	(III) PRESCRIPTION COSTS FO R ABORTION PILLS , INCLUDING 3
99	99	COSTS ASSOCIATED WIT H ABORTION PILL REVE RSALS; AND 4
100	100
101	101	(IV) COSTS OF ABORTION CAR E TRAINING PROGRAMS UNDER § 5
102	102	13–4704 OF THIS ARTICLE. 6
103	103
104	104	(B) MARYLAND MEDICAL ASSISTANCE PROGRAM FUNDS USED FO R 7
105	105	CHEMICAL OR SURGICAL ABORTION PROCEDURES SHALL BE TRACKED TO INCLUDE: 8
106	106
107	107	(1) THE TOTAL EXPENDITURE ALLOCATE D FOR CHEMICAL 9
108	108	ABORTIONS, INCLUDING ASSOCIATED PRESCRIPTION COSTS ; AND 10
109	109
110	110	(2) THE TOTAL EXPENDITUR E FOR SURGICAL ABORT IONS, 11
111	111	INCLUDING PRE – AND POST–OPERATIVE CARE . 12
112	112
113	113	(C) THE DEPARTMENT SHALL DEVE LOP A STANDARDIZED S YSTEM, 13
114	114	INCLUDING FORMS OR W ORKSHEETS, TO COLLECT CONSISTEN T DATA FROM , AS 14
115	115	APPLICABLE: 15
116	116
117	117	(1) EACH HOSPITAL LICENSED UNDER TITLE 19, SUBTITLE 3 OF THIS 16
118	118	ARTICLE; 17
119	119
120	120	(2) EACH HEALTH CARE PROVIDER LICENSED UNDER THE HEALTH 18
121	121	OCCUPATIONS ARTICLE; AND 19
122	122
123	123	(3) ANY OTHER ENTITY THAT PROVIDES A SERVICE DESCRIBED 20
124	124	UNDER SUBSECTION (A) OF THIS SECTION. 21
125	125
126	126	20–219. 22
127	127
128	128	(A) THE DEPARTMENT IS NOT REQ UIRED TO COLLECT OR REPORT DATA 23
129	129	THAT WOULD VIOLATE F EDERAL OR STATE PRIVACY LAWS . 24
130	130
131	131	(B) AN ENTITY LISTED UNDE R § 20–218(C) OF THIS SUBTITLE SHALL: 25
132	132
133	133	(1) COMPLY WITH THE DEPARTMENT ’S DATA SUBMISSION 26
134	134	REQUIREMENTS ; AND 27
135	135	4 SENATE BILL 965
136	136
137	137
138	138	(2) ANONYMIZE AND DE –IDENTIFY PATIENT DATA AS NECESSARY TO 1
139	139	COMPLY WITH APPLICAB LE LAWS. 2
140	140
141	141	20–220. 3
142	142
143	143	(A) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2025, THE 4
144	144	DEPARTMENT SHALL SUBM IT A COMPREHENSIVE R EPORT TO THE GENERAL 5
145	145	ASSEMBLY, IN ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, 6
146	146	AND MAKE THE REPORT PUBLICLY AVAILABLE O N ITS WEBSITE. 7
147	147
148	148	(B) THE REPORT SHALL INCL UDE THE FOLLOWING IN FORMATION FOR THE 8
149	149	IMMEDIATELY PRECEDIN G FISCAL YEAR: 9
150	150
151	151	(1) AGGREGATED COST DATA FOR EACH CA TEGORY OF CARE 10
152	152	DESCRIBED UNDER § 20–218(A) OF THIS SUBTITLE; 11
153	153
154	154	(2) COMPARATIVE DATA BY R EGION WITHIN THE STATE; 12
155	155
156	156	(3) ANALYSIS OF TRENDS IN THE COSTS OF EACH CA TEGORY OF CARE 13
157	157	OVER TIME; AND 14
158	158
159	159	(4) RECOMMENDATIONS , IF ANY, FOR IMPROVING COST E FFICIENCY. 15
160	160
161	161	(C) THE REPORT: 16
162	162
163	163	(1) MAY NOT INCLUDE ANY P ERSONALLY IDENTIFIAB LE 17
164	164	INFORMATION ; AND 18
165	165
166	166	(2) SHALL COMPLY WITH ALL APPLICABLE FEDERAL A ND STATE 19
167	167	PRIVACY LAWS , INCLUDING THE FEDERA L HEALTH INSURANCE PORTABILITY AND 20
168	168	ACCOUNTABILITY ACT. 21
169	169
170	170	SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect June 22
171	171	1, 2025. 23